LORI PARKER: Open Payments
NPI 1326719774 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,003 in 16 payments from 7 companies in 2025. Trend: 2023 $883 · 2024 $575 · 2025 $1,003
Food & beverage: $1,003
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $480 |
| Otsuka America Pharmaceutical, Inc. | 2 | $215 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $127 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Alkermes, Inc. | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $14 |
Products named: COBENFY, ABILIFY MAINTENA, CAPLYTA, UZEDY, VIVITROL, Qelbree, Dyanavel XR.
Industry payments across AZ — which companies pay providers there.
